Silk fibroin microparticles as carriers for delivery of human recombinant BMPs. Physical characterization and drug release

被引:110
作者
Bessa, P. C. [1 ,2 ,3 ,4 ]
Balmayor, E. R. [2 ,3 ]
Azevedo, H. S. [2 ,3 ]
Nuernberger, S. [1 ]
Casal, M. [4 ]
van Griensven, M. [1 ]
Reis, R. L. [2 ,3 ]
Redl, H. [1 ]
机构
[1] Ludwig Boltzmann Inst Expt & Clin Traumatol, AUVA Res Ctr, Austrian Cluster Tissue Regenerat, A-1200 Vienna, Austria
[2] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, European Inst Excellence Tissue Engn & Regenerat, P-4806909 Taipas, Guimaraes, Portugal
[3] IBB, PT Associated Lab, Guimaraes, Portugal
[4] Univ Minho, CBMA, Dept Biol, P-4710057 Braga, Portugal
关键词
bone morphogenetic protein; silk fibroin; microparticles; drug delivery; BMP-2; BMP-9; BMP-14; BONE MORPHOGENETIC PROTEIN-2; 3-D SCAFFOLDS; MICROSPHERES; DIFFERENTIATION; EXPRESSION; FACTOR-5; GROWTH; REGENERATION; MATRICES; DEFECTS;
D O I
10.1002/term.245
中图分类号
Q813 [细胞工程];
学科分类号
100113 [医学细胞生物学];
摘要
Bone morphogenetic proteins (BMPs) are cytokines with strong ability to promote new bone formation. Herein, we report the use of silk fibroin microparticles as carriers for the delivery of BMP-2, BMP-9 or BMP-14. BMP-containing fibroin microparticles were prepared by a mild methodology using dropwise addition of ethanol, exhibiting mean diameters of 2.7 +/- 0.3 mu m. Encapsulation efficiencies varied between 67.9 +/- 6.1 % and 97.7 +/- 2.0 % depending on the type and the amount of BMP loaded. Release kinetics showed that BMP-2, BMP-9 and BMP-14 were released in two phases profile, with a burst release in the first two days followed by a slower release, for a period of 14 days. The release data were best explained by Korsmeyer's model and the Fickian model of drug diffusion. Silk fibroin microparticles can offer a promising approach for the sustained delivery of different BMPs in tissue engineering applications. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:349 / 355
页数:7
相关论文
共 40 条
[1]
Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts) [J].
Bessa, P. C. ;
Casal, M. ;
Reis, R. L. .
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2008, 2 (01) :1-13
[2]
Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery) [J].
Bessa, P. C. ;
Casal, M. ;
Reis, R. L. .
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2008, 2 (2-3) :81-96
[3]
Expression, purification and osteogenic bioactivity of recombinant human BMP-4,-9,-10,-11 and-14 [J].
Bessa, P. C. ;
Cerqueira, M. T. ;
Rada, T. ;
Gomes, M. E. ;
Neves, N. M. ;
Nobre, A. ;
Reis, R. L. ;
Casal, M. .
PROTEIN EXPRESSION AND PURIFICATION, 2009, 63 (02) :89-94
[4]
Bourne David W. A., 2002, VVolume 121, P67
[5]
The preparation of regenerated silk fibroin microspheres [J].
Cao, Zhengbing ;
Chen, Xin ;
Yao, Jinrong ;
Huang, Lei ;
Shao, Zhengzhong .
SOFT MATTER, 2007, 3 (07) :910-915
[6]
Novel glycidyl methacrylated dextran (Dex-GMA)/gelatin hydrogel scaffolds containing microspheres loaded with bone morphogenetic proteins: Formulation and characteristics [J].
Chen, Fa-Ming ;
Zhao, Yi-Min ;
Sun, Hai-Hua ;
Jin, Tao ;
Wang, Qin-Tao ;
Zhou, Wei ;
Wu, Zhi-Fen ;
Jin, Yan .
JOURNAL OF CONTROLLED RELEASE, 2007, 118 (01) :65-77
[7]
Release of bioactive BMP from dextran-derived microspheres: A novel delivery concept [J].
Chen, FM ;
Wu, ZF ;
Sun, HH ;
Wu, H ;
Xin, SN ;
Wang, QT ;
Dong, GY ;
Ma, ZW ;
Huang, S ;
Zhang, JJ ;
Jin, Y .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 307 (01) :23-32
[8]
CHOWDARY KP, 1993, J PHARM SCI, V55, P52
[9]
The effect of growth differentiation factor-5-coated sutures on tendon repair in a rat model [J].
Dines, Joshua S. ;
Weber, Lawrence ;
Razzano, Pasquale ;
Prajapati, Rita ;
Timmer, Mark ;
Bowman, Steven ;
Bonasser, Lawrence ;
Dines, David M. ;
Grande, Daniel P. .
JOURNAL OF SHOULDER AND ELBOW SURGERY, 2007, 16 (05) :215S-221S
[10]
Hadjiioannou T.P., 1993, QUANTITATIVE CALCULA